Christian Reh

Christian Reh has over 30 years of experience in the pharmaceutical industry. Christian is currently serving as the Chief Medical Officer at Nuvisan Pharma Services GmbH, a Contract Research Organization (CRO) and pharmaceutical services provider. Prior to this, they worked as an independent consultant at Christian Reh Consulting, providing consultation and project management services to pharmaceutical companies, biotech companies, and CROs. Christian has also held various leadership roles at companies such as MAC Clinical Research GmbH, Focus Clinical Drug Development GmbH, Nuvisan GmbH, PRA International, Quintiles UK Ltd., PAREXEL GmbH, and LAB. Christian'sroles have included unit head, principal investigator, CEO, vice president, and director in various areas such as early development, clinical affairs, business development, client relations, and clinic management.

Christian Reh attended Johannes Gutenberg University Mainz from 1982 to 1988, where they earned a Doctor of Medicine (M.D.) degree with a specialization in Pharmacology.